Resumen de Investigación
Analyzed using Evidence Intelligence™

Bariatric surgery enhances beta-cell function in diabetes.

Última actualización 22 de agosto de 2026

Key finding

DI increased from 31.2 to 232.9 for RYGB (p=0.02)

Bariatric surgery, specifically gastric bypass and sleeve gastrectomy, improved beta-cell function in obese patients with type 2 diabetes.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Short-Term (≤3 mo)

Risk of bias

Some Concerns

Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

Bariatric surgery, specifically gastric bypass and sleeve gastrectomy, improved beta-cell function in obese patients with type 2 diabetes.

Clinical relevance

Improving beta-cell function is crucial for managing type 2 diabetes, as it enhances the body's ability to produce insulin. These findings suggest that bariatric surgery can be an effective treatment option for obese patients with diabetes, potentially leading to better long-term health outcomes and reduced diabetes-related complications.

Keep in mind

Limited sample size may affect generalizability. Similar outcomes for fasting glucose and insulin sensitivity could indicate limited differentiation between surgical methods. Lack of long-term follow-up data to assess sustainability of outcomes.

Published in

Referencia de la Revista

Publication details and source links for this paper.

Jamie AM, Gerardo JF, Marc B, Judith K. Bariatric surgery improves beta-cell function in obese patients with type 2 diabetes. Scientific Reports. 2019;9:1880. doi:10.1038/s41598-018-38283-y

Efectos Principales

Disposition Index increased from 31.2 to 232.9 for RYGB (p=0.02)

Disposition Index increased from 20.2 to 163.3 for SG (p=0.03)

Ghrelin levels decreased significantly post-op in the SG group (p<0.001)

No significant change in ghrelin levels after RYGB (p<0.001)

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Gastric bypass, Sleeve gastrectomy and Acute insulin response after SIIT, Disposition Index, Fasting Plasma Glucose (FPG), and 2 more.

Primary intervention

Gastric bypass

Primary outcomes

  • Acute insulin response after SIIT
  • Disposition Index
  • Fasting Plasma Glucose (FPG)

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

10
Evidence pairs
10
Relationships
2
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 64

2

Related topics

10

Evidence pairs

328

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 10 evidence relationships
  • Includes primary outcome data
  • Linked to 2 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Agrega evidencia relacionada a tu Evidence Tracker

Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.

Evidencia principal

Relación de evidencia

Bariatric Procedures and Fasting Glucose

Evidencia relacionada

Relación de evidencia

Bariatric Procedures and Insulin Resistance

Guardar evidencia

Tema de evidencia

Glycemic Control

Guardar evidencia

Core evidence

Study findings

The primary outcomes reported in this study.

Acute insulin response after SIIT

Gastric bypass → Acute insulin response after SIIT

Gastric bypass → Acute insulin response after SIIT

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Disposition Index

Gastric bypass → Disposition Index

Gastric bypass → Disposition Index

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Fasting Plasma Glucose (FPG)

Gastric bypass → Fasting Plasma Glucose (FPG)

Gastric bypass → Fasting Plasma Glucose (FPG)

Evidence Intelligence™
EvidenceScore™
79
Strong
ImpactScore™
83
Positive
ConsistencyScore™
67
generally_consistent
Estudios de apoyo: Basado en 3 estudios
Add to Evidence Tracker

Ghrelin levels measured in gingival crevicular fluid (GCF)

Gastric bypass → Ghrelin levels measured in gingival crevicular fluid (GCF)

Gastric bypass → Ghrelin levels measured in gingival crevicular fluid (GCF)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Insulin sensitivity

Gastric bypass → Insulin sensitivity

Gastric bypass → Insulin sensitivity

Evidence Intelligence™
EvidenceScore™
Moderate
Score 69 · Based on 2 studies
ImpactScore™
75
Positive
ConsistencyScore™
35
mixed
Estudios de apoyo: Basado en 2 estudios
Add to Evidence Tracker

Acute insulin response after SIIT

Sleeve gastrectomy → Acute insulin response after SIIT

Sleeve gastrectomy → Acute insulin response after SIIT

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Disposition Index

Sleeve gastrectomy → Disposition Index

Sleeve gastrectomy → Disposition Index

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Fasting Plasma Glucose (FPG)

Sleeve gastrectomy → Fasting Plasma Glucose (FPG)

Sleeve gastrectomy → Fasting Plasma Glucose (FPG)

Evidence Intelligence™
EvidenceScore™
79
Strong
ImpactScore™
83
Positive
ConsistencyScore™
67
generally_consistent
Estudios de apoyo: Basado en 3 estudios
Add to Evidence Tracker

Ghrelin levels measured in gingival crevicular fluid (GCF)

Sleeve gastrectomy → Ghrelin levels measured in gingival crevicular fluid (GCF)

Sleeve gastrectomy → Ghrelin levels measured in gingival crevicular fluid (GCF)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Insulin sensitivity

Sleeve gastrectomy → Insulin sensitivity

Sleeve gastrectomy → Insulin sensitivity

Evidence Intelligence™
EvidenceScore™
Moderate
Score 69 · Based on 2 studies
ImpactScore™
75
Positive
ConsistencyScore™
35
mixed
Estudios de apoyo: Basado en 2 estudios
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

La Evidencia Sugiere

  • RYGB significantly improved beta-cell function with a DI increase of 201.7 (p=0.02).
  • SG also improved beta-cell function with a DI increase of 143.1 (p=0.03).
  • Ghrelin levels significantly decreased in the SG group post-surgery.
who this applies

A quién se aplica

  • Obese patients diagnosed with type 2 diabetes.
  • Patients considering bariatric surgery as a treatment option.
keep in mind

Tener en Cuenta

  • Results may not apply to non-obese individuals or those without diabetes.
  • Further research is needed to explore long-term effects of these surgical interventions.
  • The study design limits the ability to draw definitive conclusions about the superiority of one surgical method over the other.
between the lines

Entre Líneas

  • Limited sample size may affect generalizability.
  • Similar outcomes for fasting glucose and insulin sensitivity could indicate limited differentiation between surgical methods.
  • Lack of long-term follow-up data to assess sustainability of outcomes.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Bariatric Procedures and Fasting Glucose, Bariatric Procedures and Fasting Glucose.

Relaciones de evidencia relacionadas

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Bariatric Procedures improve fasting glucose?

Strong Evidence

Bariatric Procedures may improve Fasting Glucose.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Fasting Plasma Glucose (FPG)

    EvidenceScore™ Strong | EvidenceScore™ 78.6 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study

Why this answer: This answer is based on 5 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
5 supporting studiesUpdated: Aug 2026

Does Bariatric Procedures improve insulin resistance?

Strong Evidence

Bariatric Procedures appears to improve Insulin Resistance.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Insulin sensitivity

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 1 study

Why this answer: This answer is based on 4 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
4 supporting studiesUpdated: Aug 2026

Does Gastric bypass improve disposition index?

Emerging Evidence

Gastric bypass appears to improve Disposition Index.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Disposition Index

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026

Does Gastric bypass improve ghrelin levels measured in gingival crevicular fluid (gcf)?

Emerging Evidence

Gastric bypass appears to improve Ghrelin levels measured in gingival crevicular fluid (GCF).

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Ghrelin levels measured in gingival crevicular fluid (GCF)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Sin anuncios. Sin rastreo.

Centrada en la evidencia, no en la publicidad.

Segura y privada

Tus datos siempre están protegidos.

Siempre al día

Se agregan nuevos estudios todos los días.